диссертации / 84

144.Bigger, J.T. RR variability in healthy? Middle-aged persons compared with patients with chronic coronary heart disease or recent acute myocardial infarction/J.T. Bigger, J.L. Fleiss, R.C. Steinman , et al. // Circulation. - 1995. -№7. -P.1936-1943.

145.Blaha, M., Blumenthal R. Risk factors: new risk-assessment guidelines—more or less personalized? // Nat Rev Cardiol. - 2014. №11. -

Р.136–7.

146.Bots, M., Sutton-Tyrrell, K. Lessons From the Past and Promises for the Future for Carotid Intima-Media Thickness// Journal of the American College of Cardiology. - 2012. -№60(17). -Р.1599-1604.

147.Buchthal, S. Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms/Buchthal SD, den Hollander JA, Merz CN, et al.// N Engl J Med. - 2000. -№342. -Р.829–835.

148.Burke, A. Effect of menopause on plaque morphologic characteristics in coronary atherosclerosis/Burke AP, Farb A, Malcolm G, et al.// Am Heart J. - 2001. -№141.-Р. S58 – S62.

149.Burke, A. Effect of risk factors on the mechanism of acute thrombosis an sudden coronary death in women/Burke AP, Farb A, Malcolm GT, et al. //Circulation. - 1998. -№97. -Р.2110–2126.

150.Buyukkaya, R. The evaluation of carotid intima-media thickness and visceral obesity as an atherosclerosis predictor in newly-diagnosed polycystic ovary syndrome. /Buyukkaya R, Besir FH, Yazgan S., et al.//Clin Ter. - 2014. -№165(1). - e6-11.

151.Camici. PG, Crea, F. Coronary microvascular dysfunction//N Engl J Med. - 2007. -№356. -Р. 830 – 840.

152.Canto, J. Symptom presentation of women with acute coronary syndromes. Myth vs reality/Canto JG, Goldberg RJ, Han MM, et al. // Arch Intern Med. - 2007. -№167. -Р.2405–13.

251

153.Caprio, S. Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity / S.Caprio, G.Plewe, M.Diamond, et al. // J. Pediatr. - 1989. - Vol.114. - P.963-967.

154.Caro, JF. Insulin resistance in obese and nonobese men // J Clin Endocrinol Metab. - 1991. -№73. - Р.691-95.

155.Castelli, WP. Cardiovascular disease: pathogenesis, epidemiology, and risk among users of oral contraceptives who smoke// Am J ObstetGynecol. - 1999. -№180. -Р.S349 – S356.

156.Catov, J. Prior preterm birth and maternal subclinical cardiovascular disease 4 to 12 years after pregnancy/Catov JM, Dodge R, Barinas-Mitchell E, et al. // Womens Health (Larchmt). - 2013. -№22(10).- Р.835-43.

157.Cattaneo, A. Overweight and obesity in infants and pre-school children in the European Union: a review of existing data/Cattaneo A, Monasta L, Stamatakis E, et al.// Obes Rev.- 2010. -№11. -Р.389 – 398.

158.Chakrabarti, J. Serum Leptin Level in Women with Polycystic Ovary Syndrome: Correlation with Adiposity, Insulin, and Circulating Testosterone // Ann Med Health Sci Res. - 2013. -№3(2). -Р.191–6.

159.Chakrabati, S., Morton, J., Davidge, S. Mechanisms of estrogen effects on the endothelium: an overview// Canadian Journal of cardiology. -

2014._№30 (7).-Р.705-12.

160.Chalasani, N. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology /Chalasani N, Younossi Z, Lavine JE, et al. //Gastroenterology. - 2012. -№142. -Р.1592–609.

161.Chen, M. The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome/Chen MJ, Yang WS, Chen CL, et al. //Hum Reprod 2008.-№23. - Р.952–7.

252

162.Childhood obesity surveillance in the WHO European Region WHO/Europe, 2007/ URL: http://www.euro.who.int/en/what-we-do/health- topics/noncommunicable-diseases/obesity/facts-and-figures

163.Ciccone, M. Plasma leptin is independently associated with the intimamedia thickness of the common carotid artery/Ciccone M, Vettor R, Pannacciulli N, et al. // Int J Obes Relat Metab Disord. - 2001. -№25(6). -

Р.805-10.

164.Li, S. Cigarette smoking exacerbates the adverse effects of age and metabolic syndrome on subclinical atherosclerosis: the Bogalusa Heart Study /Li S., Yun M., Fernandez C., et al. // PLoS One. - 2014. -№9(5). - Р.e96368.

165.Clayton, T. Do men benefit more than women from an interventional strategy in patients with unstable angina or non-ST-elevation myocardial infarction? The impact of gender in the RITA3 trial/Clayton TC, Pocock SJ, Henderson RA, et al.//Eur Heart J. - 2004. -№25. -Р.1641 – 50.

166.Colditz, G. Weight gain as a risk factor for clinical diabetes mellitus in women/Colditz GA, Willett WC, Rotnitzky A, Manson JE.// Ann Intern Med. - 1995. -№122(7). -Р.481-6.

167.Collins, P. 17 beta-estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease/Collins P, Rosano GM, Sarrel PM,et al.// Circulation. - 1995. -№92. -Р.24 – 30.

168.Cook, NR, Buring, JE, Ridker, PM. The effect of including C-reactive protein in cardiovascular risk prediction models for women// Ann Intern Med. - 2006. -№145.-Р.21 – 29.

169.Cornier, M-A. Assessing adiposity: a scientific statement from the American Heart Association/Cornier M-A, Després J-P, Davis N, et al.//Circulation. - 2011. -124. -Р.1996–2019.

170.Cote, A. Childhood Obesity and Cardiovascular Dysfunction/Cote AT, Harris KC, Panagiotopoulos C, et al.// J Am Coll Cardiol. - 2013/ -

№62(15).Р.1309-19.

253

171.Coutinho, T. Arterial stiffness and its clinical implications in women//Can J Cardiol. - 2014. -№30(7). -Р.756-64.

172.Coylewright, M, Reckelhoff, JF, Ouyang, P. Menopause and hypertension. An age-old debate//Hypertension. - 2008. -№51. - Р.952 – 9.

173.Cruz, M. Acute dilatation to phytoestrogens and estrogen receptor subtypes expression in small arteries from women with coronary heart disease/Cruz MN, Agewall S, Schenck-Gustafsson K, et al.//Atherosclerosis. - 2008. -№196. -Р.49 – 58.

174.Cuspidi, C. Left-ventricular hypertrophy and obesity: a systematic review and meta-analysis of echocardiographic studies /Cuspidi C, Rescaldani M, Sala C, et al.// J Hypertens. - 2014.-№32(1).-Р.16-25.

175.D’Agostino, R. General cardiovascular risk profile for use in primary

care—the Framingham Heart study/D’Agostino RB, Vasan RS, Pencina MJ,

et al. // Circulation. - 2008. -№117. -Р.743–53.

176.Dai, W., Li, Y., Zheng, H. Estradiol/Testosterone imbalance: Impact on coronary heart disease risk factors in postmenopausal women // Cardiology. - 2012. - №121. - P. 249-254.

177.Daviglus, M. Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality/Daviglus ML, Stamler J, Pirzada A, et al.// JAMA. - 2004. -№292. -Р.1588 – 1592

178.DECODE Study Group. Gluсose tolerance and cardiovascular mortality, comparsion of fasting and 2-hour diagnostic criteria // Arch Intern Med.- 2001.- №61.- Р. 397-404.

179.Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: Report of WHO/IDF Consultation. - Geneva: World Health Organization, 2006.- р.

180.Definition, Diagnosis, and Classification of Diabetes Mellitus and Its Complications: Report of a WHO consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus (WHO/NCD/NCS/99.2). - Geneva: World Health Organization, 1999.-р.

254

181.Dey, S. Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events/Dey S, Flather MD, Devlin G, et al. // Heart. - 2009. -№95. -Р.20–26.

182.Dhaliwal, SS, Welborn, TA. Central obesity and multivariable cardiovascular risk as assessed by the Framingham prediction scores//Am J Cardiol. - 2009. -№103. -Р.1403–7.

183.Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study// Lancet. –2009. -№374(9702): 1677–1686 .

184.Diabetic cardiology /Edited by M. Fisher, JJ McMurray. - John Wiley and Sons Ltd., 2007. - 295 p.

185.Dobbelsteyn, C. A comparative evaluation of waist circumference, waist-to-hip ratio and body mass index as indicators of cardiovascular risk factors. The Canadian Heart Health Surveys/Dobbelsteyn CJ, Joffres MR, MacLean DR, et al.//Int J Obes. - 2001. -№25. -Р.652–61.

186.Dorn, JM. Body mass index and mortality in a general population sample women of men and women: the Buffalo Health Study/Dorn JM, Schisterman EF, Winkelstein W, et al.// Am J Epidemiol.-1997. - 146.-Р.919–

31.

187.Doyle, M. Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease./Doyle M, Weinberg N, Pohost GM, et al.// J Am Coll Cardiol Img. - 2010. -№3. -Р.1030 – 6.

188.Drew, BS, Dixon, AF, Dixon, JB. Obesity management: update on orlistat//Vasc Health Risk Manag. - 2007. -№3. -Р.817 – 821.

189.Du, T. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance /Du T., Yuan G., Zhang M., et al. // Cardiovasc Diabetol. - 2014. - №13(1). -

Р.146.

255

190.Dunstan, D. Breaking up prolonged sitting reduces postprandial glucose and insulin responses/Dunstan DW, Kingwell BA, Larsen R, et al.// Diabetes Care. - 2012. -№35(5). -Р.976-83.

191.Ello-Martin, J. Dietary energy density in the treatment of obesity: a year-long trial comparing 2 weight-loss diets / Ello-Martin JA, Roe LS, Ledikwe JH, et al. // Am J Clin Nutr. – 2007. - №85(6). –Р.1465-77.

192.Engeli, S., Sharma, A.M. The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension// J Mol Med. - 2001. -№ 79. - Р. 21–9.

193.Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report // Pediatrics. - 2011. -

№128 Suppl 5. -Р. S213–256.

194.Fauser, B., Tarlatzis, B., Rebar, R. Consensus on women’s health

aspects of polycystic ovary syndrome (PCOS)//Fertility and Sterility. - 2012.

-№97 (1). -Р.28-38

195.Flint, A. Excess weight and the risk of incident coronary heart disease among men and women /Flint AJ, Hu FB, Glynn RJ, et al.// Obesity (Silver Spring). - 2010. -№18 (2). -Р.377-83.

196.Flint, A. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies / A. Flint, A. Raben, JE. Blundell, et al. // International Journal of Obesity. – 2000. -•№24.

–Р.38-48.

197.Fraser, A. Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children / Fraser A, Nelson SM, Macdonald-Wallis C, et al. // Circulation. - 2012. -№20. -125(11).-Р.1367-80.

198.Freiberg, M. BMI vs. waist circumference for identifying vascular risk

/ Freiberg MS, Pencina MJ, D’Agostino RB, et al.// Obesity (Silver Spring). -

2008. - №16. - Р.463 – 9.

256

199.Frink, RJ. Gender gap, inflammation and acute coronary disease: are women resistant to atheroma growth? Observations at autopsy// J Invasive Cardiol. - 2009. -№ 21. -Р.270 – 277.

200.Fry, J, Finley, W. The prevalence and costs of obesity in the EU// Proc Nutr Soc. -2005. -№64. –Р.359 – 362.

201.Gast, G-C. Menopausal complaints are associated with cardiovascular risk factors / Gast G-C., Grobbee D., Pop V., et al. //Hypertension.- 2008. -

№51. -Р.1492–8.

202.Gast, G-CM. Vasomotor menopausal symptoms are associated with increased risk of coronary heart disease/Gast G-CM, Pop VJ, Samsioe GN, et al.//Menopause. - 2011. -№ 18. -Р.146 – 51.

203.Gauthier, A. The leptin to adiponectin ratio is a marker of the number of metabolic syndrome criteria in French adults /Gauthier A, Dubois S, Bertrais S, et al. // J Metabol Syndr. - 2011. -№1(1). -Р.2-6.

204.Gil-Campos, M., Canete, R., Gil A. Adiponectin, the missing link in insulin resistance and obesity // Clin Nutr. - 2004. -№23(5). -Р.963-74.

205.Global health risks: mortality and burden of disease attributable to selected major risks. - World Health Organization Press, 2009. - 62p.

206.Global Status Report on Noncommunicable Diseases 2010: Description of the global burden of NCDs, their risk factors and determinants. - WHO, 2011. - 176 p.

207.Go, A. Heart disease and stroke statistics—2014 update: a report from the American Heart Association / Go AS, Mozaffarian D, Roger VL, et al.// Circulation. - 2014. -№129. - Р.e28-292.

208.Goff, D. ACC/AHA guideline on the assessment of cardiovascular risk 2013: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines/Goff D., Lloyd-Jones D., Bennett G. et al. //Circulation. - 2014. - №129. -Р.S49–73.

209.Goh, LG. Anthropometric measurements of general and central obesity and the prediction of cardiovascular disease risk in women: a cross-sectional

257

study/Goh LGH, Dhaliwal SS, Welborn TA, et al.// BMJ Open. - 2014. -№4.

- Р.e004138.

210.Gonçalves Campana, E. Blood pressure in adolescence, adipokines and

inflammation in young adults. The Rio de Janeiro Study / Gonçalves Campana E., Araujo Brandão A, Pozzan R, et al. //Arq Bras Cardiol. - 2014. -№ 102(1).

-Р.60-69.

211. Gregg, E. Mortality trends in men and women with diabetes, 1971 to 2000 / Gregg EW, Gu Q, Cheng YJ, et al. //Ann Intern Med/ - 2007/ -№147.

-Р.149 – 155.

212.Grundy, S. Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: medical office assessment / Grundy SM, Bazzarre T, Cleeman J, et al.// Circulation. - 2000. -№101.-Р.E3 – E11.

213.Guideline for the management of overweight and obesity in adults 2013 AHA/ACC/TOS: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society/ Jensen MD, Ryan DH, Apovian CM, et al.//Circulation. - 2013.-№

214.Guidelines for the management of arterial hypertension ESH/ESC 2013: The Task Force for the management of arterial hypertension of the ESH and of the ESC // Journal of Hypertension. - 2013. -№31 (7). -Р.1281–1357.

215.Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)// Atherosclerosis. - 2011. -№217 (Suppl 1). -Р. S1-44.

216.Gulati, M. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease / Gulati M, Cooper-DeHoff RM, McClure C, et al.// Arch Intern Med. - 2009. -№169. -Р.843 – 50.

217.Gunderson, E. History of gestational diabetes mellitus and future risk of atherosclerosis in mid-life: the Coronary Artery Risk Development in

258

Young Adults study/Gunderson EP, Chiang V, Pletcher MJ, et al. // J Am

Heart Assoc. - 2014. -№12. - 3(2). - e000490.

218.Haslam, DW, James, WP. Obesity// Lancet. - 2005. -№366. -Р.1197 –

1209.

219.He, J. Passive smoking and the risk of coronary heart disease—a metaanalysis of epidemiologic studies / He J, Vupputuri S, Allen K, et al. // N Engl J Med. - 1999. -№340. -Р.920 – 926.

220.Heer, T. Gender differences in acute myocardial infarction in the era of reperfusion (the MITRA registry)/Heer T, Schiele R, Schneider S, et al. // Am J Cardiol.-2002.-№89. -Р.511 – 517.

221.Helfand, M. Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force/Helfand M, Buckley DI, Freeman M, et al.//Ann Intern Med. - 2009. -№151. -Р.496 – 507.

222.Hellings, W. Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome. A prognostic study. /Hellings WE, Peeters W, Moll FL, et al. //Circulation. - 2010. -№121.-Р.1941 – 1950.

223.Hellings, W. Gender-associated differences in plaque phenotype of patients undergoing carotid endarteriectomy / Hellings WE, Pasterkamp G, Verhoeven BAN, et al.// J Vasc Surg. - 2007. -№45. -Р.289 – 297

224.Herder, M. The metabolic syndrome and progression of carotid

atherosclerosis over 13 years. The Tromsø study/Herder M, Arntzen KA,

Johnsen SH, et al.// Cardiovasc Diabetol. - 2012-№27(11). -Р.77.

225.Ho, S. Association between simple anthropometric indices and cardiovascular risk factors/Ho SC, Chen YM, Woo JLF, et al. // Int J Obes Relat Metab Disord. - 2001. -№25. -Р.1689–97.

226.Hochman, J. Sex, clinical presentation, and outcome in patients with acute coronary syndromes/Hochman JS, Tamis JE, Thompson TD, et al.// N Engl J Med. - 1999. -№341. -Р.226 – 32.

259

227.Hokanson, JE, Austin, MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies// J Cardiovasc Risk. - 1996. -№3. -Р.213 – 219.

228.Hu, F. Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women /Hu FB, Li TY, Colditz GA, et al.//JAMA. - 2003. -№289(14). -Р.1785-91.

229.Huang, A, Kaley, G. Gender-specific regulation of cardiovascular function: estrogen as key player//Microcirculation. - 2004. -№11.-Р.9 – 38.

230.Huang, K-C. Obesity in the elderly and its relationship with cardiovascular risk factors in Taiwan/Huang K-C, Lee M-S, Lee S-D, et al.//Obes Res. - 2005. -№13.-Р.170–8.

231.Hubert, HB. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study/Hubert HB, Feinleib M, McNamara PM, et al.// Circulation. - 1983. -

№67. - P. 968–77.

232.Huxley, R, Barzi, F, Woodward, M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies//BMJ. - 2006. -№332. -Р.73–78.

233.IDF DIABETES ATLAS: Sixth edition. - International Diabetes Federation, 2013. - 159p.

234.Incidence of diabetes following ramipril or rosiglitazone withdrawal /DREAM Trial Investigators// Diabetes Care. - 2011/ - №34(6). - Р.1265-9.

235.International Diabetes Federation: Global Guideline for Type 2 diabetes. - International Diabetes Federation, 2012. - р.

236.Jacobs, AK. Coronary intervention in 2009. Are women no different than men?// Circ Cardiovasc Intervent. - 2009. -№2. -Р.69–78.

237.Jedrychowski, W. Excessive weight and hypertension in the elderly –

the results of the community study/Jedrychowski W., Mroz E., Bojanczyk M.,

et al. // Arch Gerontol Geriatr. - 1991. -№ 13(1). -Р.61–9.

260